SHW
71
-2
VRSN
50
-5
COST
51
-3
SYY
50
-8
TRV
64
-3
HPQ
62
2
WYNN
34
-3
SWK
80
2
IFF
60
-3
PCG
74
-6
NTRS
47
-2
EIX
69
-5
MNST
52
2
MS
50
-8
MA
65
-4
APD
42
-2
JBHT
49
3
ES
55
-5
PWR
60
-2
DVN
35
2
SHW
71
-2
VRSN
50
-5
COST
51
-3
SYY
50
-8
TRV
64
-3
HPQ
62
2
WYNN
34
-3
SWK
80
2
IFF
60
-3
PCG
74
-6
NTRS
47
-2
EIX
69
-5
MNST
52
2
MS
50
-8
MA
65
-4
APD
42
-2
JBHT
49
3
ES
55
-5
PWR
60
-2
DVN
35
2
Financhill
Back

iBio Quote, Financials, Valuation and Earnings

How to Profit From "America's Earnings" Reports

New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
19

IBIO
iBio

Last Price:
1.89
Seasonality Move:
-34.73%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

iBio Price Quote

$1.89
+0.10 (+5.59%)
(Updated: September 19, 2024 at 6:40 PM ET)

iBio Key Stats

Sell
19
iBio (IBIO) is a Sell
Day range:
$1.78 - $1.94
52-week range:
$1.02 - $7.83
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.62%
Volume:
45.5K
Avg. volume:
63.7K
1-year change:
-73.67%
Market cap:
$15.4M
Revenue:
$0
EPS:
$-4.99

How Much Does iBio Make?

Data Unavailable

Is iBio Growing As A Company?

Data Unavailable

iBio Stock Price Performance

  • Did iBio Stock Go Up Last Month?
    iBio share price went up by 1.7% last month
  • Did IBIO's Share Price Rise Over The Last Year?
    IBIO share price fell by -73.67% over the past 1 year

What Is iBio 52-Week High & Low?

  • What Is iBio’s 52-Week High Share Price?
    iBio has traded as high as $7.83 over the past 52 weeks
  • What Is iBio’s 52-Week Low Share Price?
    iBio has traded as low as $1.02 over the past 52 weeks

iBio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy iBio?

  • How Much Debt Does iBio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does iBio Have?
    Cash and short term investments quarterly total is $5.3M
  • What Is iBio’s Book Value Per Share?
    Book value per share is 2.92

Is iBio Cash Flow Positive?

  • What Is IBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$18.7M
  • What Is iBio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $14.2M
  • What Is iBio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1M

iBio Return On Invested Capital

Data Unavailable

iBio Earnings Date & Stock Price

  • What Is iBio's Stock Price Today?
    A single share of IBIO can be purchased today for 1.79
  • What Is iBio’s Stock Symbol?
    iBio trades on the nyam under the ticker symbol: IBIO
  • When Is iBio’s Next Earnings Date?
    The next quarterly earnings date for iBio is scheduled on September 24, 2024
  • When Is IBIO's next ex-dividend date?
    iBio's next ex-dividend date is September 19, 2024
  • How To Buy iBio Stock?
    You can buy iBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

iBio Competitors

  • Who Are iBio's Competitors?
    Below is a list of companies who compete with iBio or are related in some way:
    • NovaBay Pharmaceuticals Inc (NBY)
    • Nanoviricides Inc (NNVC)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

iBio Dividend Yield

  • What Is IBIO Dividend Yield?
    iBio’s dividend yield currently is 0%
  • What Is iBio’s Payout Ratio?
    iBio’s payout ratio is 0%
  • When Did iBio Last Pay A Dividend?
    The latest dividend pay date is September 19, 2024
  • What Is iBio’s Dividend Per Share?
    iBio pays a dividend of $0.00 per share

iBio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.30
Upside from Last Price: 140.22%

Major Shareholders

  • How many IBIO shares are owned by institutional investors?
    3.3M IBIO shares are owned by institutional investors
  • How many IBIO shares are owned by insiders?
    8.1M IBIO shares are owned by insiders